What it's actually good for
Fisetin is a flavonoid found in strawberries, apples, persimmons, and onions that has become one of the most talked-about compounds in the longevity supplement world — almost entirely on the strength of one 2018 mouse study. Yousefzadeh and colleagues screened ten flavonoids for senolytic activity (the ability to selectively clear "zombie" senescent cells that accumulate with age and drive chronic inflammation) and found fisetin was the most potent of the group. In aged mice, it reduced senescence markers (p16, p21) and inflammatory SASP factors, restored tissue homeostasis, and extended median and maximum lifespan even when dosing started late in life. That is a genuinely striking result, and it's why fisetin gets discussed in the same breath as dasatinib+quercetin as a leading senolytic candidate. What it is not, yet, is a proven human intervention. Senescent cell burden and its consequences are real biology, but "kills senescent cells in old mice" and "does something useful in a 45-year-old human taking a capsule" are two different claims separated by a lot of unresolved pharmacology.
What the research says
Senescent cell clearance and healthspan (Grade C — preclinical, not human-proven). The mouse data is the whole case for fisetin right now. It's a well-designed study from a serious aging-biology lab, and the effect size (lifespan extension from a late-life intervention) is large by the standards of the field. But it's one study, in mice, and senolytic effects that look clean in animal models have a track record of getting messier in humans — dosing, timing, and which tissues actually clear senescent cells all remain open questions. The Mayo Clinic's AFFIRM and AFFIRM-LITE trials, registered on ClinicalTrials.gov, are testing pulsed fisetin dosing in older adults with frailty and inflammation markers. As of this writing those trials have not reported definitive efficacy results, which is the main reason this stays a Grade C claim rather than climbing toward B.
Bioavailability is a real obstacle, not a footnote. Fisetin is poorly absorbed orally — a first human pharmacokinetic study found that a hybrid-hydrogel formulation raised peak blood levels and total exposure more than 20-fold compared with plain fisetin at the same dose. That means the mouse dosing (often delivered by injection or as a percentage of chow, achieving tissue concentrations hard to replicate with an oral capsule) may not translate directly to what a standard supplement can deliver. Anyone taking fisetin on the strength of the mouse study should understand that oral absorption alone is an unsolved problem, independent of whether the senolytic effect holds up in humans at all.
How much, and which form
There is no established human dose because there is no completed efficacy trial to establish one from. Supplement doses in the 100–500 mg/day range are common, and some formulations use intermittent "hit" dosing (e.g., two consecutive days per month) modeled loosely on the pulsed regimens used in senolytic research, rather than daily use. Given the bioavailability problem above, formulations using liposomal delivery or fat-based absorption enhancers have a plausible rationale, but none have been validated against clinical outcomes.
Safety & interactions
Early human trials have dosed fisetin up to roughly 20 mg/kg without major tolerability issues, but the safety database is thin and short-term. There is no long-term human safety data at supplement doses, and the mechanism itself is a reason for caution: a compound that kills cells selectively, even senescent ones, is not obviously risk-free if that selectivity is imperfect in living tissue over years of use. This is informational, not medical advice — check with a clinician before starting, especially if pregnant, nursing, on medication, or managing a chronic condition.
How we picked the brand
A fisetin product earns a spot when it addresses the bioavailability problem directly (enhanced-absorption formulation rather than plain powder in a capsule), discloses actual fisetin content per serving, and comes from a manufacturer with third-party testing.